| Literature DB >> 30197597 |
Antonis Ekizos1,2, Alessandro Santuz1,2, Arno Schroll1,2, Adamantios Arampatzis1,2.
Abstract
The maximum Lyapunov exponent (MLE) has often been suggested as the prominent measure for evaluation of dynamic stability of locomotion in pathological and healthy population. Although the popularity of the MLE has increased in the last years, there is scarce information on the reliability of the method, especially during running. The purpose of the current study was, thus, to examine the reliability of the MLE during both walking and running. Sixteen participants walked and ran on a treadmill completing two measurement blocks (i.e., two trials per day for three consecutive days per block) separated by 2 months on average. Six different marker-sets on the trunk were analyzed. Intraday, interday and between blocks reliability was assessed using the intraclass correlation coefficient (ICC) and the root mean square difference (RMSD). The MLE was on average significantly higher (p < 0.001) in running (1.836 ± 0.080) compared to walking (1.386 ± 0.207). All marker-sets showed excellent ICCs (>0.90) during walking and mostly good ICCs (>0.75) during running. The RMSD ranged from 0.023 to 0.047 for walking and from 0.018 to 0.050 for running. The reliability was better when comparing MLE values between blocks (ICCs: 0.965-0.991 and 0.768-0.961; RMSD: 0.023-0.034 and 0.018-0.027 for walking and running respectively), and worse when considering trials of the same day (ICCs: 0.946-0.980 and 0.739-0.844; RMSD: 0.042-0.047 and 0.045-0.050 for walking and running respectively). Further, different marker-sets affect the reliability of the MLE in both walking and running. Our findings provide evidence that the assessment of dynamic stability using the MLE is reliable in both walking and running. More trials spread over more than 1 day should be considered in study designs with increased demands of accuracy independent of the locomotion condition.Entities:
Keywords: Lyapunov analysis; humans; local dynamic stability; locomotion; methodology; nonlinear dynamics; reliability
Year: 2018 PMID: 30197597 PMCID: PMC6117405 DOI: 10.3389/fphys.2018.01101
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Schematic representation of the measurement design. All participants completed two blocks of measurements. Every block included three consecutive days of measurements (two trials per day). The design was the same in walking and running.
Figure 2Marker placement on the participants' trunk. Spine: 1st, 6th, 10th, 12th thoracic vertebrae and 2nd lumbar vertebrae. Scapulae: acromion, superior and inferior angle.
Figure 3Overlaying graphs of boxplots and scatterplots depicting the maximum Lyapunov exponent (MLE) values in all marker-sets, during walking. Circles exhibit the individual values of the participants. *Statistically significant effect of marker position on the resulting MLE values (p < 0.05).
The resulting p-values and F statistic from the repeated measures ANOVA, the Intraclass Correlation Coefficient (ICC) with the corresponding upper (U) and lower (L) bounds of confidence intervals and the mean ±standard deviation Root Mean Square Differences (RMSD) for all marker-sets, when considering: both trials within the same day (within days); the averaged values of trials (between days); the averaged values of the consecutive days (between blocks).
| T1 | 0.978 | 0.045 ± 0.012 | 0.980 | 0.039 ± 0.013 | 0.983 | 0.033 ± 0.025 | |||
| U: 0.992 | U: 0.992 | U: 0.994 | |||||||
| L: 0.938 | L: 0.954 | L: 0.953 | |||||||
| T6 | 0.946 | 0.047 ± 0.018 | 0.971 | 0.034 ± 0.009 | 0.965 | 0.034 ± 0.022 | |||
| U: 0.981 | U: 0.989 | U: 0.988 | |||||||
| L: 0.858 | L: 0.934 | L: 0.905 | |||||||
| T10 | 0.966 | 0.045 ± 0.018 | 0.975 | 0.037 ± 0.010 | 0.982 | 0.029 ± 0.020 | |||
| U: 0.988 | U: 0.991 | U: 0.994 | |||||||
| L: 0.906 | L: 0.945 | L: 0.951 | |||||||
| L2 | 0.979 | 0.042 ± 0.013 | 0.984 | 0.036 ± 0.011 | 0.987 | 0.027 ± 0.024 | |||
| U: 0.993 | U: 0.994 | U: 0.996 | |||||||
| L: 0.943 | L: 0.963 | L: 0.958 | |||||||
| ALL | 0.980 | 0.042 ± 0.013 | 0.985 | 0.034 ± 0.012 | 0.991 | 0.023 ± 0.018 | |||
| U: 0.993 | U: 0.994 | U: 0.997 | |||||||
| L: 0.945 | L: 0.967 | L: 0.972 | |||||||
| SP | 0.973 | 0.044 ± 0.012 | 0.982 | 0.035 ± 0.010 | 0.984 | 0.030 ± 0.019 | |||
| U: 0.993 | U: 0.995 | U: 0.996 | |||||||
| L: 0.945 | L: 0.968 | L: 0.966 | |||||||
The values refer to the walking condition.
Figure 4Exemplary (i.e., one participant and one marker-set) divergence curves for all trials, averaged over days and averaged per block during walking.
Figure 5Overlaying graphs of boxplots and scatterplots depicting the maximum Lyapunov exponent (MLE) values in all marker-sets, during running. Circles exhibit the individual values of the participants. *Statistically significant effect of marker position on the resulting MLE values (p < 0.05).
The resulting p-values and F statistic from the repeated measures ANOVA, the Intraclass Correlation Coefficient (ICC) with the corresponding upper (U) and lower (L) bounds of confidence intervals and the mean ±standard deviation Root Mean Square Differences (RMSD) for all marker-sets, when considering: both trials within the same day (within days); the averaged values of trials (between days); the averaged values of the consecutive days (between blocks).
| 0.739 | 0.049 ± 0.014 | 0.688 | 0.045 ± 0.017 | 0.768 | 0.027 ± 0.031 | ||||
| U: 0.899 | U: 0.864 | U: 0.913 | |||||||
| L: 0.418 | L: 0.435 | L: 0.449 | |||||||
| 0.844 | 0.045 ± 0.012 | 0.846 | 0.040 ± 0.016 | 0.940 | 0.023 ± 0.014 | ||||
| U: 0.943 | U: 0.937 | U: 0.979 | |||||||
| L: 0.595 | L: 0.688 | L: 0.835 | |||||||
| 0.822 | 0.049 ± 0.013 | 0.857 | 0.039 ± 0.013 | 0.931 | 0.024 ± 0.017 | ||||
| U: 0.935 | U: 0.942 | U: 0.976 | |||||||
| L: 0.547 | L: 0.709 | L: 0.802 | |||||||
| 0.819 | 0.046 ± 0.015 | 0.822 | 0.043 ± 0.011 | 0.941 | 0.021 ± 0.015 | ||||
| U: 0.934 | U: 0.927 | U: 0.979 | |||||||
| L: 0.545 | L: 0.648 | L: 0.842 | |||||||
| 0.781 | 0.050 ± 0.011 | 0.794 | 0.042 ± 0.011 | 0.872 | 0.027 ± 0.021 | ||||
| U: 0.918 | U: 0.915 | U: 0.953 | |||||||
| L: 0.476 | L: 0.599 | L: 0.679 | |||||||
| 0.842 | 0.048 ± 0.010 | 0.870 | 0.038 ± 0.014 | 0.961 | 0.018 ± 0.015 | ||||
| U: 0.943 | U: 0.948 | U: 0.986 | |||||||
The values refer to the running condition.
Figure 6Exemplary (i.e., one participant and one marker-set) divergence curves for all trials, averaged over days and averaged per block during running.